130 related articles for article (PubMed ID: 1709961)
1. Role of normal serum in the binding of lipopolysaccharide to IgG fractions from rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Glennon M; de Deckker FA; Tello D
J Infect Dis; 1991 Jun; 163(6):1256-66. PubMed ID: 1709961
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
4. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
de Jongh-Leuvenink J; Vreede RW; Marcelis JH; de Vos M; Verhoef J
Infect Immun; 1985 Dec; 50(3):716-20. PubMed ID: 3905612
[TBL] [Abstract][Full Text] [Related]
8. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
[TBL] [Abstract][Full Text] [Related]
9. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.
Bhattacharjee AK; Opal SM; Palardy JE; Drabick JJ; Collins H; Taylor R; Cotton A; Cross AS
J Infect Dis; 1994 Sep; 170(3):622-9. PubMed ID: 8077720
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
Baumgartner JD; Heumann D; Calandra T; Glauser MP
J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
[TBL] [Abstract][Full Text] [Related]
12. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
[TBL] [Abstract][Full Text] [Related]
13. Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum.
Warren HS; Knights CV; Siber GR
J Infect Dis; 1986 Nov; 154(5):784-91. PubMed ID: 3095436
[TBL] [Abstract][Full Text] [Related]
14. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G.
Tomita GM; Todhunter DA; Hogan JS; Smith KL
J Dairy Sci; 1995 Dec; 78(12):2745-52. PubMed ID: 8675757
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
[TBL] [Abstract][Full Text] [Related]
16. Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5.
Hellman J; Loiselle PM; Zanzot EM; Allaire JE; Tehan MM; Boyle LA; Kurnick JT; Warren HS
J Infect Dis; 2000 Mar; 181(3):1034-43. PubMed ID: 10720528
[TBL] [Abstract][Full Text] [Related]
17. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
Weiss J; Beckerdite-Quagliata S; Elsbach P
J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
[TBL] [Abstract][Full Text] [Related]
18. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
Tyler JW; Spears H; Nelson R
J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive affinity purification of immunoglobulin recognizing common gram-negative bacterial core antigens.
Tyler JW; Cullor JS; Dellinger JD
J Immunol Methods; 1990 May; 129(2):221-6. PubMed ID: 2191044
[TBL] [Abstract][Full Text] [Related]
20. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
Trautmann M; Hahn H
Infection; 1985; 13(3):140-5. PubMed ID: 3897069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]